Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on November 16, 2005
J Am Soc Nephrol 17: 122-130, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005080802

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005080802v1
17/1/122    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeller, G. C.
Right arrow Articles by Kelley, V. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeller, G. C.
Right arrow Articles by Kelley, V. R.

Basic Immunology and Pathology

Inducible Co-Stimulator Null MRL-Faslpr Mice: Uncoupling of Autoantibodies and T Cell Responses in Lupus

Geraldine C. Zeller*, Junichi Hirahashi*, Andreas Schwarting{dagger}, Arlene H. Sharpe{ddagger} and Vicki R. Kelley*

* Laboratory of Molecular Autoimmune Disease, Renal Division, Brigham and Women’s Hospital, Boston, Massachusetts; {dagger} Department of Internal Medicine, Renal Division, Johannes-Gutenberg-University of Mainz, Mainz, Germany; and {ddagger} Department of Pathology, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts

Address correspondence to: Dr. Vicki Rubin Kelley, Harvard Institute of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115. Phone: 617-525-5915; Fax: 617-525-5830; E-mail: vkelley{at}rics.bwh.harvard.edu

MRL/MpJ-Tnfrsf6lpr (MRL-Faslpr) mice develop a spontaneous T cell–dependent autoimmune disease that shares features with human lupus, including fatal nephritis, systemic pathology, and autoantibodies (autoAb). The inducible co-stimulator (ICOS) is upregulated on activated T cells and modulates T cell–mediated responses. To investigate whether ICOS has an essential role in regulating autoimmune lupus nephritis and the systemic illness in MRL-Faslpr mice, ICOS null (–/–) MRL Faslpr and ICOS intact (+/+) MRL-Faslpr strains (wild-type [WT]) were generated and compared. It was determined that in ICOS–/– MRL-Faslpr as compared with the WT strain, (1) there is a significant reduction in circulating IgG and double-stranded DNA autoantibody isotype titers, and (2) there is an amplification of the frequency of intrarenal T cells generating IFN-{gamma} and TNF-{alpha} in ICOS–/– versus WT mice. Of note, eliminating ICOS in the MRL-Faslpr strain does not alter renal pathology or function. Despite the reduction in circulating IgG and autoantibody isotypes (G1, G2a, and G2b), the amount of these IgG isotypes depositing in kidneys is similar. Furthermore, the systemic illness (skin, salivary and lacrimal glands, lungs, lymphadenopathy, and splenomegaly) is equivalent in ICOS–/– MRL-Faslpr and WT mice. These findings highlight the danger of relying on individual parameters, such as quantitative serum Ig levels and T cell functions, as prognostic indicators of lupus.




This article has been cited by other articles:


Home page
LupusHome page
S. Datta and C Mauri
Signalling defects and cellular interactions (2)
Lupus, March 1, 2008; 17(3): 247 - 250.
[PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP